Trial
NCT04482621
Decitabine for Coronavirus (COVID-19) Pneumonia- Acute Respiratory Distress Syndrome (ARDS) Treatment: DART Trial
Phase IISUSPENDEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Johns Hopkins University
Collaborators
—
Condition
COVID-19
Intervention
Decitabine
Why stopped
IRB00247544 is lapsed. Separate application submitted for reactivation under IRB00521868. Awaiting review \& approval
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-08-29